Mitochondrial DNA copy number in whole blood and glioma risk: A case control study

Abstract

Alterations in mitochondrial DNA (mtDNA) copy number are observed in human gliomas. However, whether variations in mtDNA copy number in whole blood play any role in glioma carcinogenesis is still largely unknown. In current study with 395 glioma patients and 425 healthy controls, we intended to investigate the association between mtDNA copy number in whole blood and glioma risk. Overall, we found that levels of mtDNA copy number were significantly higher in glioma cases than healthy controls (mean: 1.48 vs. 1.32, P < 0.01). In both cases and controls, levels of mtDNA copy number were inversely correlated with age (P < 0.01, respectively). And in cases, newly diagnosed, glioblastoma (GBM), and high grade glioma patients had significantly lower mtDNA copy number than their counterparts (P = 0.02, P < 0.01, and P = 0.04, respectively). In the multivariate analysis, elevated mtDNA copy number levels were associated with a 1.63-fold increased risk of glioma (adjusted odds ratio (OR) = 1.63, 95% confidence interval (CI) = 1.23-2.14). In further quartile analysis, study subjects who had highest levels of mtNDA copy number had 1.75-fold increased risk of gliomas (adjOR = 1.75, 95%CI = 1.18-2.61). In brief, our findings support the role of mtDNA copy number in the glioma carcinogenesis. © 2016 Wiley Periodicals, Inc.

Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis

“…Our analysis included 36 studies that focused on diverse cancer types from different origins around the world 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 . To reduce the uncertainty induced by confusing factors in the meta-analysis, we evaluated the association between mtDNA content with cancer risk in an overall analysis, as well as stratified analyses by cancer types, genders, ages, ethnicity and life styles.…”

Global DNA hypomethylation in leukocytes associated with glioma risk

“…For this case-control study, glioma patients were recruited from The University of Texas MD Anderson Cancer Center (Houston, TX). Detailed information on these cases has been reported previously [ 34 ]. All patients with either newly diagnosed or previously treated histopathologically confirmed glioma who were registered at MD Anderson between April 2014 and July 2016 were eligible for our study.…”

Mitochondrial DNA Copy Number Variation as a Potential Predictor of Renal Cell Carcinoma

“…In previous years, numerous retrospective and prospective studies have demonstrated a powerful association between increased peripheral blood mtDNA copy number and the risk of different types of cancer (6,7,(20)(21)(22)(23)(24). However, the link between blood mtDNA and carcinogenesis is not fully explained.…”